Verily, Google’s life sciences division, is undergoing another round of layoffs as part of a strategic restructuring. CEO Stephen Gillett announced the workforce reductions in a memo, emphasizing a shift towards core priorities like precision health, data, and AI. The company is winding down its Devices program, impacting employees who contributed to medical device innovations.